Beta-Glucan Particles as Vaccine Adjuvant Carriers.

about

Immunology of Cryptococcal Infections: Developing a Rational Approach to Patient Therapy.

P2860

Q54953513-D5430F93-7CE4-430B-BBB1-71718E4EFDBC

P2860

Beta-Glucan Particles as Vaccine Adjuvant Carriers.

Item

http://www.wikidata.org/entity/Q50957928

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Beta-Glucan Particles as Vaccine Adjuvant Carriers.

@en

Beta-Glucan Particles as Vaccine Adjuvant Carriers.

@nl

type

Item

label

Beta-Glucan Particles as Vaccine Adjuvant Carriers.

@en

Beta-Glucan Particles as Vaccine Adjuvant Carriers.

@nl

prefLabel

Beta-Glucan Particles as Vaccine Adjuvant Carriers.

@en

Beta-Glucan Particles as Vaccine Adjuvant Carriers.

@nl

P1476

Beta-Glucan Particles as Vaccine Adjuvant Carriers.

@en

P2093

Ernesto R Soto

http://www.w3.org/2001/XMLSchema#string

Fusun Dikengil

http://www.w3.org/2001/XMLSchema#string

Gary R Ostroff

http://www.w3.org/2001/XMLSchema#string

Stuart M Levitz

http://www.w3.org/2001/XMLSchema#string

Zeynep Mirza

http://www.w3.org/2001/XMLSchema#string

P2860

Beyond empiricism: informing vaccine development through innate immunity research

Robust stimulation of humoral and cellular immune responses following vaccination with antigen-loaded beta-glucan particles

Exploiting fungal cell wall components in vaccines

Relative contributions of dectin-1 and complement to immune responses to particulate β-glucans.

Protection against Experimental Cryptococcosis following Vaccination with Glucan Particles Containing Cryptococcus Alkaline Extracts.

Distinct patterns of dendritic cell cytokine release stimulated by fungal beta-glucans and toll-like receptor agonists.

Characterization and optimization of the glucan particle-based vaccine platform.

Beta-glucan recognition by the innate immune system.

Glucan particles for macrophage targeted delivery of nanoparticles.

Orally delivered siRNA targeting macrophage Map4k4 suppresses systemic inflammation.

P304

143-157

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/978-1-4939-7104-6_11

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

1625

http://www.w3.org/2001/XMLSchema#string

P577

2017-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28584989

http://www.w3.org/2001/XMLSchema#string

Beta-Glucan Particles as Vaccine Adjuvant Carriers.

about

P2860

P2860

Beta-Glucan Particles as Vaccine Adjuvant Carriers.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P577

P698